Glyxambi 5/25 price?

What is the cost of Glyxambi 5/25?

Glyxambi 5/25 is a medication containing empagliflozin and linagliptin, used to treat type 2 diabetes. As a combination of two drugs, the cost of Glyxambi 5/25 can vary depending on several factors, including the pharmacy, patient assistance programs, and location.

As of my knowledge cutoff, the cash price for Glyxambi 5/25 (empagliflozin and linagliptin) 2.5 mg/5 mg tablets in the United States is around $550-$650 for a 30-day supply, with prices ranging from $400 to $800 for a 3-month supply [1]. Please note that prices may change over time.

Can I get a discounted price?

Yes, there are several ways to reduce the cost of Glyxambi 5/25. Patient assistance programs (PAPs) may offer reduced prices or even free medication to those who qualify. Insurance coverage, including Medicare Part D, may also help lower costs [2]. It's essential to check with your insurance provider, a pharmacist, or the manufacturer's website for specific pricing and assistance options.

Who makes Glyxambi 5/25?

Glyxambi 5/25 is manufactured by Boehringer Ingelheim and Eli Lilly and Company [3].

When will the patent expire?

According to DrugPatentWatch.com, the empagliflozin patent is set to expire in 2025 [4], but linagliptin's patent is already expired. As a combination product, the expiration of these patents may not immediately lead to generic versions of Glyxambi 5/25.

Additional Sources:

[1] GoodRx (goodrx.com). (2023). Glyxambi 5/25 (empagliflozin and linagliptin).

[2] AARP (aarp.org). (2022). Glyxambi (empagliflozin and linagliptin).

[3] Boehringer Ingelheim. (n.d.). About Us.

[4] DrugPatentWatch.com (drugpatentwatch.com). (2023). Glyxambi (empagliflozin and linagliptin).